Inventor
WESTERGAARD MAJKEN
DK17 patents
⚠️ This page may combine multiple inventors who share the name “WESTERGAARD MAJKEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANTARIS PHARMA AS
6 patentsUS7687617B2Mar 30, 2010
Oligonucleotides with alternating segments of locked and non-locked nucleotides
SANTARIS PHARMA AS207 citations98
US9428534B2Aug 30, 2016
Antisense design
SANTARIS PHARMA AS46 citations97
US7589190B2Sep 15, 2009
Potent LNA oligonucleotides for the inhibition of HIF-1A expression
SANTARIS PHARMA AS129 citations95
US7622453B2Nov 24, 2009
Oligomeric compounds for the modulation of Bcl-2
SANTARIS PHARMA AS114 citations94
US8026355B2Sep 27, 2011
Oligomeric compounds for the modulation of survivin expression
SANTARIS PHARMA AS10 citations82
US9447138B2Sep 20, 2016
Potent LNA oligonucleotides for the inhibition of HIF-1a expression
SANTARIS PHARMA AS1 citations52
ROCHE INNOVATION CT COPENHAGEN AS
5 patentsUS9708614B2Jul 18, 2017
Antisense design
ROCHE INNOVATION CT COPENHAGEN AS28 citations97
US9994850B2Jun 12, 2018
Antisense design
ROCHE INNOVATION CT COPENHAGEN AS4 citations83
US9951333B2Apr 24, 2018
Antisense design
ROCHE INNOVATION CT COPENHAGEN AS0 citations51
US9890383B2Feb 13, 2018
Antisense design
ROCHE INNOVATION CT COPENHAGEN AS0 citations51
US9938527B2Apr 10, 2018
Potent LNA oligonucleotides for the inhibition of HIF-1A expression
ROCHE INNOVATION CT COPENHAGEN AS0 citations49